摘要
目的观察沐舒坦辅助治疗婴儿肺炎的临床疗效。方法96例婴儿肺炎随机分为两组,治疗组(n=52)在对照组(n=44)综合治疗的基础上加用沐舒坦压缩雾化吸入治疗。结果治疗组在临床症状、体征消失时间,缩短病程等方面均较对照组缩短(x2=5.24,p<0.05),差异有显著性。结论沐舒坦压缩雾化吸入辅助治疗婴儿肺炎疗效显著。
Objective To observe the clinical effect of Ambroxol as a supporting medication on infant pneumonia. Methods 96 cases of infant pneumonia were divided into two groups： the treatment group （n=52） and the control group （44）. The patients in control group were treated with inhalation of compressed Ambroxol moist on the base of combined therapy. Results The time needed for the disappearance of clinical symptoms and signs and the recovery period in the treatment group is statistically less than that of the control group （χ^2=-5.24, p〈0.05）. Conclusions Inhalation of compressed Ambroxol moist is an effective medication for infant pneumonia.
出处
《海南医学》
CAS
2006年第8期8-8,4,共2页
Hainan Medical Journal
关键词
沐舒坦
婴儿肺炎
压缩雾化吸入
Ambroxol, infant pneumonia, inhalation of compressed moist
